We have no real way of knowing whether our ancestors boasted similar growth-oriented tendencies or not, but there is enough evidence to suggest that they did. While they might not have gone about it as aggressively as the modern generation, they had, at the end of the day, a forward leaning stance. Now, one might make a claim regarding people being, in fact, a little overboard today with their pursuit of scaling up, and in all honesty, maybe the argument would be legitimate as well. However, on the other hand, you can also view it in a light where we just have more mediums at our disposal than any of the previous generations; hence the world is relatively much better positioned to clock meaningful efforts. When you give it an in-depth look, you’ll find many factors contributing towards the expansion of these mediums, but none will ever have the stature of technology. Technology’s bid to become a phenomenon is almost entirely rooted in how it seamlessly changed the way every major sector used to work. The transition got these areas to a smarter version of themselves, and one sector that can vouch for the consequential results concerns our healthcare landscape. Technology and healthcare link-up won’t just upgrade a few things here and there. Instead, it will go the yards to redefine what medical care means. Even after that goal is accomplished, technology’s stewardship will continue guiding us towards brighter horizons, and a recent development by the researchers at University of Pennsylvania School of Medicine does everything to further the said cause.
The researching team at University of Pennsylvania School of Medicine has successfully developed a new nanoparticles’ coating, which is essentially designed to protect them against any immunity attacks. Powered by naturally occurring proteins, the approach, on the back of limiting nanoparticles destruction, ensures that they reach the target tissues, thus setting the stage for more effective nanotherapies. Up until now, various experts have coined new ways to maximize nanoparticles’ vast treatment potential, but the sticking point in all those theories has been our complement proteins and their tendency to attack unprotected nanoparticles, resulting in inflammation, phagocytosis by white blood cells, and eventual nanoparticles’ destruction. To deal with this scenario, researchers across the board have devised different coating layers, and yet despite the huge volume of them already available, UPenn’s take on it stands out rather comfortably. Basically, the new method strives to inhibit the reactionary complement system and offer nanoparticles all the required protection, as they try to reach a particular tissue.
So far, the researching team has observed encouraging results within the conducted tests, and if it ends up working out, the coating can also be used for medical devices like stents and catheters.
